Mushrooms are magical … and not just for creating psychogenic phenomena in vision quests. They are a seemingly never ending source of potential pharmaceuticals and biologics.
Azole antifungal drugs can inhibit the fungal sterol 14α-demethylase, a cytochrome P450-dependent enzyme involved in synthesis of ergosterol, a key component of the fungal cell wall, from the precursor lanosterol. The resulting backed up accumulation of the 14α-methylsterols, disrupts the fungal cell membrane, stopping further growth.
These azole antifungal drugs that were developed to combat pathogenic yeast infections, were found to also inhibit the mammalian cytochrome P450-C19 aromatase/estrogen synthetase. [see Azole antifungal aromatase inhibitors - verifications and updates]. They block estrogen production, and are used in breast cancer treatment.
Keep reading with a 7-day free trial
Subscribe to BioMedWorks’ Newsletter to keep reading this post and get 7 days of free access to the full post archives.